Considering that the mechanisms of HDAC inhibition in patients with CTCL is poorly understood, the HAT/HDAC genetic alterations were of specific interest. The gene discussed is TMPRSS11D; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.